Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel.
Ann Hematol. 2024 Jun;103(6):1909-1917. doi: 10.1007/s00277-024-05736-6. Epub 2024 Apr 20.
Ann Hematol. 2024.
PMID: 38642304
Review.
Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
Hur P, Lomax KG, Ionescu-Ittu R, Manceur AM, Xie J, Cammarota J, Gautam R, Sanghera N, Kim N, Grom AA.
Hur P, et al.
Pediatr Rheumatol Online J. 2021 Sep 14;19(1):143. doi: 10.1186/s12969-021-00605-2.
Pediatr Rheumatol Online J. 2021.
PMID: 34521444
Free PMC article.
Item in Clipboard
Cite
Cite